We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.80
Bid: 55.80
Ask: 56.80
Change: 0.80 (1.43%)
Spread: 1.00 (1.792%)
Open: 55.00
High: 56.80
Low: 55.00
Prev. Close: 56.00
AXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

18 Sep 2018 07:00

RNS Number : 0420B
Accsys Technologies PLC
18 September 2018
 

 

AIM: AXS

Euronext Amsterdam: AXS

18 September 2018

 

ACCSYS TECHNOLOGIES PLC("Accsys" or "the Company")

 

Annual General Meeting Statement

 

Accsys, the fast growing and sustainable chemical technology group, today announces that in advance of its Annual General Meeting, to be held at 2.30 p.m. (UK time) this afternoon, its Chief Executive, Paul Clegg, has made the following comments:

 

"I am pleased to report that total revenue for the five months to 31 August 2018 increased by 10% to €26.7m (2017: €24.3m) (unaudited). Accoya® production volumes increased to 16,918 cubic metres in the same period (2017:16,124 cubic metres), reflecting the continued constraint on the current existing capacity in Arnhem.

 

In the period we successfully commissioned the third Accoya® reactor in Arnhem and have been carrying out planned gradual production volume increases since July. Demand continues to exceed our current production levels and we therefore expect production and sales volumes to increase substantially over the remainder of the financial year.

 

We continue to make good progress in respect of the construction of the Tricoya® plant in Hull, with significant construction work having been undertaken on site. The key equipment is starting to be delivered to the site and we expect completion of construction in mid-2019 calendar year.

 

In July we announced additional funding which will allow us to develop key new growth markets more quickly including USA and Asia, where we are in discussions with potential partners who are interested in developing new production capacity for both Accoya® and Tricoya®. It will also enable us to accelerate certain projects to further increase the capacity and efficiency of the Arnhem plant beyond 60,000 cubic metres.

 

Our interim financial statements for the six months ended 30 September 2018 are expected to be released on 20 November 2018."

 

 

ACCSYS TECHNOLOGIES PLC ("Accsys" of "de Vennootschap")

 

Verklaring jaarlijkse algemene vergadering

 

Accsys, de snelgroeiende en duurzame chemische technologiegroep, kondigt vandaag aan dat in de aanloop naar haar jaarlijkse algemene vergadering, die om 14.30 uur (Engelse tijd) zal worden gehouden vanmiddag de Chief Executive, Paul Clegg, de volgende opmerkingen heeft gemaakt:

 

"Ik ben verheugd te kunnen melden dat de totale omzet in de vijf maanden tot 31 augustus 2018 met 10% is gestegen ten opzichte van dezelfde periode vorig jaar tot €26,7 miljoen (2017: €24,3 miljoen) (niet gecontroleerd). Het productievolume van Accoya is in dezelfde periode gestegen tot 16.918 kubieke meter (2017: 16.124 kubieke meter) ondanks de beperking in die periode van de bestaande capaciteit van Arnhem.

In deze periode hebben we de derde Accoya®-reactor in bedrijf genomen en hebben we sinds juli volgens plan het productievolume geleidelijk opgevoerd. De vraag blijft ons huidige productieniveau overstijgen en we verwachten derhalve dat productie- en verkoopvolume in de rest van het boekjaar aanzienlijk zullen stijgen.

 

Zoals aangekondigd in onze financiële resultaten in juni, boeken we opnieuw goede vooruitgang met de bouw van de Tricoya®-fabriek in Hull, waar aanzienlijke bouwwerkzaamheden op de locatie zijn uitgevoerd. Met de levering van de belangrijkste apparatuur wordt begonnen vóór de voltooiing van de bouw, die medio 2019 wordt verwacht.

 

In juli kondigden we aanvullende financiering aan waarmee we belangrijke nieuwe groeimarkten sneller kunnen ontwikkelen, waaronder de Verenigde Staten en Azië, waar we in gesprek zijn met potentiële partners die geïnteresseerd zijn in het ontwikkelen van nieuwe productiecapaciteit voor zowel Accoya® als Tricoya®. Het zal ons ook in staat stellen om bepaalde projecten te versnellen om de capaciteit en efficiëntie van de fabriek in Arnhem verder te verhogen tot boven de 60.000 kubieke meter.

 

Onze tussentijdse financiële staten voor de zes maanden eindigend op 30 september 2018 zullen naar verwachting worden vrijgegeven op 20 november 2018.''

 

Ends

 

For further information, please contact:

 

Accsys Technologies PLC

Paul Clegg, CEO

Will Rudge, FD

Hans Pauli, Executive Director, Corporate Development

via MHP Communications

Numis Securities

Nominated Adviser:

Jamie Lillywhite

 

Corporate Broking:

Christopher Wilkinson

Ben Stoop

+44 (0) 20 7260 1000

 

MHP Communications

Tim Rowntree

Kelsey Traynor

+44 (0) 20 3128 8100

Off the Grid (The Netherlands)

Frank Neervoort

Yvonne Derkse

+31 681 734 236

+31 622 379 666

 

 

Notes to editors:

 

Accsys Technologies PLC (www.accsysplc.com) is a chemical technology group whose primary focus is on the production of Accoya® wood and Tricoya® wood elements, technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in London, United Kingdom, an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc.) and technology licensing associated with the acetylation of wood elements via its subsidiary Tricoya Technologies Limited. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'. Accsys' operations comprise four principal business units: (i) Accoya® wood production; (ii) building and operating of Tricoya® wood chip acetylation plant in Hull; (iii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iv) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Accoya® Wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. These benefits result in lower maintenance and total cost of ownership while using a highly sustainable and environmentally responsible building material. For a full archive of Accoya® news, visit www.accoya.com/news.

Tricoya® Wood Elements (www.tricoya.com) are produced using Accsys' proprietary technology for the acetylation of wood chips and particles for use in the fabrication of panel products such as medium density fibreboard and particle-board. These products demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Exploitation of Accsys' proprietary technology relating to Tricoya® Wood Elements is carried out through Tricoya Technologies Limited. Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process which increases the amount of naturally occurring 'acetyl' molecules in wood, thereby changing its physical properties. When carried out to a sufficient level throughout the wood, this process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

 

Accsys Technologies is the trading name of Titan Wood Limited. Accoya®, Tricoya® and the Trimarque Device are registered trademarks owned by Titan Wood Limited ("TWL"), a wholly owned subsidiary of Accsys Technologies PLC, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMFKODPCBKDFCD
Date   Source Headline
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM
12th Dec 20237:00 amRNSDirectorate Change
27th Nov 20239:57 amRNSNotifiable Interest - De Engh B.V.
27th Nov 20239:33 amRNSNotifiable Interest – Teslin
24th Nov 202312:21 pmRNSNotifiable Interest – De Engh B.V.
21st Nov 20233:37 pmRNSResults of Capital Raise
21st Nov 20237:04 amRNSHalf-year Report
21st Nov 20237:00 amRNSIssue of Equity
20th Sep 20235:12 pmRNSResults of Annual General Meeting 2023
15th Sep 20233:54 pmRNSNotifiable Interest - De Engh
12th Sep 20237:00 amRNSDirectorate Change
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
1st Sep 20237:00 amRNSTotal Voting Rights
1st Sep 20237:00 amRNSTrading Update
17th Aug 20235:01 pmRNSNotice of Annual General Meeting 2023
28th Jul 20237:00 amRNSDirector Interests and LTIP Awards
26th Jul 20237:00 amRNSDirectorate Appointment
21st Jul 20233:46 pmRNSAnnual Report and Financial Statements 2023
27th Jun 20237:00 amRNSPreliminary results for the year end 31 March 2023
19th Jun 202312:48 pmRNSChange of Registered Office
6th Jun 20237:00 amRNSDirectorate Update
12th May 202311:21 amRNSBlock Listing Application to AIM
3rd May 20237:00 amRNSTrading Update
4th Apr 20237:00 amRNSCEO Appointment
24th Mar 20237:00 amRNSDirectorate Appointments
2nd Mar 20236:00 pmRNSBlock Listing Six Monthly Return
2nd Mar 20236:00 pmRNSTotal Voting Rights
26th Jan 20237:00 amRNSAccsys Trading Update
15th Dec 20223:55 pmRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSDirectorate Change
6th Dec 20223:43 pmRNSNotifiable Interest - De Engh
6th Dec 20223:36 pmRNSNotifiable Interest - Teslin Participaties
22nd Nov 20227:00 amRNSInterim Results for six months ended 30 Sept 2022
17th Nov 20222:58 pmRNSIssue of Equity
10th Nov 20224:37 pmRNSHolding(s) in Company
8th Nov 20225:09 pmRNSHolding(s) in Company
2nd Nov 20227:00 amRNSUpdate on Tricoya – Consortium restructure
1st Nov 20224:12 pmRNSNotice of HY Results and Total Voting Rights
23rd Sep 20224:20 pmRNSResult of AGM
12th Sep 20227:00 amRNSAccsys Trading Update
23rd Aug 20224:49 pmRNSNotice of AGM
23rd Aug 20222:35 pmRNSBlock Listing Application to AIM
3rd Aug 20227:00 amRNSDirectorate Change
27th Jul 20225:56 pmRNSAnnual Report
12th Jul 202210:40 amRNSDirector Interests and LTIP Awards
12th Jul 202210:16 amRNSGrant of Awards under Accsys Deferred Bonus Plan
30th Jun 20227:00 amRNSPreliminary results for the year end 31 March 2022
10th Jun 20227:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.